STRATEGIC USE OF FURAN IN THE SYNTHESIS OF MOLECULES OF BIOLOGICAL IMPORTANCE
STRATEGIC USE OF FURAN IN THE SYNTHESIS OF MOLECULES OF BIOLOGICAL IMPORTANCE
批准号:
7721467
负责人:
Dennis L. Wright
金额:
$0.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2009-01-31
关键词:
AlkenesAreaBicyclo CompoundsBiologicalBiological FactorsCarbonCationsComplexComputer Retrieval of Information on Scientific Projects DatabaseCyclizationEthersEthyl EtherFacility Construction Funding CategoryFundingFuransGenerationsGrantInstitutionLeadLinkMacrolidesMethodologyMethodsObject AttachmentOctanesPhysical condensationPlacementProcessPyransReactionResearchResearch PersonnelResourcesSchemeShowdomycinSkeletonSourceStructureSystemUnited States National Institutes of HealthVariantadductcycloadditioncytotoxicenolfuraninterestoctaneoxidationprogramsviridin C
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Our group?s primary focus has been the strategic use of furan in the synthesis of complex molecules of biological importance. We are currently exploring three target-driven methodologies and their application to natural product total synthesis.
1. Electrochemical Furan Annulations:
The application of furans as flexible building blocks in synthesis has been an area of ongoing interest in my research group. We have developed a new method for the construction of annulated furans through a key electro-oxidative cyclization. The general strategy begins with a two step annulation reaction that involves a silyl promoted addition of a furyl substituted cuprate to an enone followed by an anodic oxidation to couple the nascent enol ether and the furan. Owing to the diversity of structures available from furan, these intermediates can serve as precursors to a variety on natural product skeletons. We are currently applying this methodology to the synthesis erincacine C and viridin.
2. Synthesis of Pyrans by Ring Opening Cross Metathesis:
Another major focus of my program is on the application of ring-opening cross metathesis reactions to bridged bicyclic compounds (Scheme 2). The ready availability of oxabicyclo[3.2.1]octene derivatives from furan makes them powerful building blocks for heterocycle synthesis through ring-opening. Our strategy, utilizing alkene metathesis, links the ring opening with the generation of a new carbon-carbon bond to prepare differentially substituted pyrans. The majority of our studies thus far have focused on the intermolecular cross-metathesis. We have also demonstrated the intramolecular variant of this process that lead to spiro, linear and bridged fused systems depending on placement of the unsaturated tether. We are currently employing these pyran building blocks in the modular construction of the cytotoxic macrolide leucascandrolide.
3. Versatile oxabicyclic building blocks from cyclopropenes:
Although oxabicyclo[3.2.1]octane building blocks are typically prepared by Noyori-type cycloadditions between furan and oxyallyl cations, it has been known for decades that analogous systems are available from direct condensation of furan and tetrahalocyclopropenes. While these reactions have been of mechanistic interest, they have remained virtually unexplored from a synthetic perspective. We have used these adducts as direct precursors to various oxabicyclic building blocks, several of which are now available in chiral form. These building blocks are being used as precursors for synthesis of showdomycin and colchicines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Agents Targeting Cryptococcal Infections
-
批准号:10697960
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:Dennis L. Wright
-
依托单位:
New Agents for the Treatment on Mycobacteria Avium Infections
-
批准号:10597233
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Dennis L. Wright
-
依托单位:
New Agents for the Treatment on Mycobacteria Avium Infections
-
批准号:10482476
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Dennis L. Wright
-
依托单位:
Development of Broad Spectrum Antifungal Agents
-
批准号:9909111
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Dennis L. Wright
-
依托单位:
Antimetabolites for Acute Myeloid Leukemias
-
批准号:9909414
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Dennis L. Wright
-
依托单位:
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
-
批准号:9178633
-
项目类别:
-
资助金额:$69.68万
-
财政年份:2013
-
负责人:Dennis L. Wright
-
依托单位:
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
-
批准号:8960331
-
项目类别:
-
资助金额:$62.75万
-
财政年份:2013
-
负责人:Dennis L. Wright
-
依托单位:
HDAC Inhibitors Inspired by Natural Products
-
批准号:8191877
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2011
-
负责人:Dennis L. Wright
-
依托单位:
HDAC Inhibitors Inspired by Natural Products
-
批准号:8293024
-
项目类别:
-
资助金额:$16.31万
-
财政年份:2011
-
负责人:Dennis L. Wright
-
依托单位:
Potent Antifolates as New Therapeutics for MRSA
-
批准号:8089567
-
项目类别:
-
资助金额:$76.37万
-
财政年份:2006
-
负责人:Dennis L. Wright
-
依托单位:
STRATEGIC USE OF FURAN IN THE SYNTHESIS OF MOLECULES OF BIOLOGICAL IMPORTANCE
-
批准号:7355282
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2006
-
负责人:Dennis L. Wright
-
依托单位:
Potent and selective DHFR inhibitors for treating Cryptosporidiosis
-
批准号:7161659
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2006
-
负责人:Dennis L. Wright
-
依托单位:
Potent Antifolates as New Therapeutics for MRSA
-
批准号:8002596
-
项目类别:
-
资助金额:$75.42万
-
财政年份:2006
-
负责人:Dennis L. Wright
-
依托单位:
Natural feedstocks for diversity oriented synthesis
-
批准号:6833401
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:Dennis L. Wright
-
依托单位:
Natural feedstocks for diversity-oriented synthesis
-
批准号:7109033
-
项目类别:
-
资助金额:$51.72万
-
财政年份:2004
-
负责人:Dennis L. Wright
-
依托单位:
Natural feedstocks for diversity-oriented synthesis
-
批准号:7228088
-
项目类别:
-
资助金额:$48.11万
-
财政年份:2004
-
负责人:Dennis L. Wright
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: